Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL)

This study has been completed.
Sponsor:
Collaborator:
World Health Organization
Information provided by (Responsible Party):
AB Foundation
ClinicalTrials.gov Identifier:
NCT01635777
First received: July 3, 2012
Last updated: July 9, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)